| Literature DB >> 27698514 |
Pallab Pahari1, Ujwal Pratim Saikia2, Trinath Prasad Das3, Chendil Damodaran3, Jurgen Rohr4.
Abstract
Synthetic scheme for the preparation of a number of different derivatives of anticancer natural product Psoralidin is described. A convergent synthetic approach is followed using simple starting materials like substituted phenyl acetic esters and benzoic acids. The developed synthetic route leads us to complete the first synthesis of an analogous natural product Lespeflorin I1, a mild melanin synthesis inhibitor. Preliminary bioactivity studies of the synthesized compounds are carried out against two commonly used prostate cancer cell lines. Results show that the bioactivity of the compounds can be manipulated by the simple modification of the functional groups.Entities:
Year: 2016 PMID: 27698514 PMCID: PMC5044874 DOI: 10.1016/j.tet.2016.04.066
Source DB: PubMed Journal: Tetrahedron ISSN: 0040-4020 Impact factor: 2.457